Hospital Universitario Vall d'Hebron — Barcelona, Catalonia

Public research footprint of Hospital Universitario Vall d'Hebron, compiled from the ClinicalTrials.gov public registry.

463

Registered studies

188

Active

Recruiting now

169

Completed

Stopped or withdrawn

Most-studied conditions

ALK-positive Non-small Cell Lung Cancer (NSCLC) · B-cell Non-Hodgkin Lymphoma (B-NHL) · Niemann-Pick Type C Disease · Non-Transfusion-dependent Alpha-Thalassemia

Recently updated registry entries

NCT07023627 — A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin… (Recruiting)
NCT07416526 — A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in… (Recruiting)
NCT07623200 — A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Hospital Universitario Vall d'Hebron?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.